Clinical trial reportNature medicinePublished
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
13 of 57 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Nature medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Cyclophosphamide; Camptothecin; Doxorubicin; Antineoplastic Combined Chemotherapy Protocols; Immunoconjugates; Neoplasm Staging; Treatment Outcome; Neoadjuvant Therapy; Adult; Aged
- PubMed ID
- 39277671
- PubMed Central ID
- PMC12044543
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked